Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the publication of a milestone article on its blood test for the accurate and early detection of ovarian cancer. Highlights A benchmarking study comparing CLEO’s ovarian cancer blood test against ultrasound has been published…
Metals Acquisition (MAC) (NYSE:MTAL,ASX:MAC) has signed a strategic investment deal with Polymetals Resources (ASX:POL), which is working to restart…
CleanTech Lithium PLC (AIM: CTL, Frankfurt:T2N, OTCQX:CTLHF), an exploration and development company, advancing sustainable lithium projects in Chile for…
Levi & Korsinsky notifies investors that it has commenced an investigation of Roblox Corporation (‘Roblox’) (NYSE:RBLX) concerning possible violations…